Exact Mass: 587.2057368
Exact Mass Matches: 587.2057368
Found 171 metabolites which its exact mass value is equals to given mass value 587.2057368
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536) [HMDB] This compound is an intermediate in N-glycan biosynthesis, and the byproduct of N-acetylglucosaminyldiphosphodolichol (EC 2.4.1.141) and UDP-N-acetylglucosamine-dolichyl-phosphate (EC 2.7.8.15). (KEGG) This compound and its corresponding enzymes are implicated in the developmental programmes of a variety of eukaryotes. (PMID: 10024536).
7-(3-((3-Acetylphenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Nothramicin
An anthracycline antibiotic isolated from the culture broth of Nocardia sp. MJ896-43F17. It exhibits significant antimycobacterial activity against several drug-resistant Mycobacterium smegmatis strains.
7beta-hydroxy-6beta-(3,4,5-trimethoxybenzoyloxy)-3alpha-(E)-(3,4,5-trimethoxycinnamoyloxy)tropane
6-[2-ethoxy-2-(2,4,5-trimethoxyphenyl)]ethyl-7,8-dimethoxy-5-methyl-2,3-methylenedioxy-5,6-dihydrobenzo[c]phenanthridine|buesgeniine
3,10,11-triacetoxy-8beta-(4-acetoxybenzyl)-2-methoxyberbine|3,10,11-triacetoxy-8beta-<4-acetoxybenzyl>-2-methoxyberbine
Brominated Phosphatidylcholine C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Brominated Phosphatidylcholine mz 2+ C24H47BrNO8 - putative - Functions on the acyl moity have unknown location
Cys Phe Arg Tyr
Cys Phe Tyr Arg
Cys Arg Phe Tyr
Cys Arg Tyr Phe
Cys Tyr Phe Arg
Cys Tyr Arg Phe
Asp His Met Trp
Asp His Trp Met
Asp Met His Trp
Asp Met Trp His
Asp Gln Tyr Tyr
Asp Trp His Met
Asp Trp Met His
Asp Tyr Gln Tyr
Asp Tyr Tyr Gln
Glu Asn Tyr Tyr
Glu Tyr Asn Tyr
Glu Tyr Tyr Asn
Phe Cys Arg Tyr
Phe Cys Tyr Arg
Phe Met Gln Tyr
Phe Met Tyr Gln
Phe Gln Met Tyr
Phe Gln Tyr Met
Phe Arg Cys Tyr
Phe Arg Tyr Cys
Phe Tyr Cys Arg
Phe Tyr Met Gln
Phe Tyr Gln Met
Phe Tyr Arg Cys
Gly Trp Tyr Tyr
Gly Tyr Trp Tyr
Gly Tyr Tyr Trp
His Asp Met Trp
His Asp Trp Met
His Met Asp Trp
His Met Trp Asp
His Trp Asp Met
His Trp Met Asp
Met Asp His Trp
Met Asp Trp His
Met Phe Gln Tyr
Met Phe Tyr Gln
Met His Asp Trp
Met His Trp Asp
Met Gln Phe Tyr
Met Gln Tyr Phe
Met Trp Asp His
Met Trp His Asp
Met Tyr Phe Gln
Met Tyr Gln Phe
Asn Glu Tyr Tyr
Asn Tyr Glu Tyr
Asn Tyr Tyr Glu
Gln Asp Tyr Tyr
Gln Phe Met Tyr
Gln Phe Tyr Met
Gln Met Phe Tyr
Gln Met Tyr Phe
Gln Tyr Asp Tyr
Gln Tyr Phe Met
Gln Tyr Met Phe
Gln Tyr Tyr Asp
Arg Cys Phe Tyr
Arg Cys Tyr Phe
Arg Phe Cys Tyr
Arg Phe Tyr Cys
Arg Tyr Cys Phe
Arg Tyr Phe Cys
Trp Asp His Met
Trp Asp Met His
Trp Gly Tyr Tyr
Trp His Asp Met
Trp His Met Asp
Trp Met Asp His
Trp Met His Asp
Trp Tyr Gly Tyr
Trp Tyr Tyr Gly
Tyr Cys Phe Arg
Tyr Cys Arg Phe
Tyr Asp Gln Tyr
Tyr Asp Tyr Gln
Tyr Glu Asn Tyr
Tyr Glu Tyr Asn
Tyr Phe Cys Arg
Tyr Phe Met Gln
Tyr Phe Gln Met
Tyr Phe Arg Cys
Tyr Gly Trp Tyr
Tyr Gly Tyr Trp
Tyr Met Phe Gln
Tyr Met Gln Phe
Tyr Asn Glu Tyr
Tyr Asn Tyr Glu
Tyr Gln Asp Tyr
Tyr Gln Phe Met
Tyr Gln Met Phe
Tyr Gln Tyr Asp
Tyr Arg Cys Phe
Tyr Arg Phe Cys
Tyr Trp Gly Tyr
Tyr Trp Tyr Gly
Tyr Tyr Asp Gln
Tyr Tyr Glu Asn
Tyr Tyr Gly Trp
Tyr Tyr Asn Glu
Tyr Tyr Gln Asp
Tyr Tyr Trp Gly
N-Acetyl-D-glucosaminyldiphosphodolichol
C23H43NO12P2 (587.2260378000001)
Aurora A Inhibitor I
2-[Ethyl[3-[[4-[[1-[2-[(3-fluorophenyl)amino]-2-oxoethyl]-1H-pyrazol-4-yl]amino]quinazolin-7-yl]oxy]propyl]amino]ethyl dihydrogen phosphate
5-O-(4,4-Dimethoxytrityl)-N4-acetyl-2-deoxycytidine
C32H33N3O8 (587.2267538000001)
3-Hexadecyl-1-methyl-1H-imidazolium 1,1,1-Trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide
Vestipitant Mesylate
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
9-(Dimethylamino)-1-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutyl}-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium perchlorate
C29H34ClN3O8 (587.2034314000001)
3-({1-[3-Carbamimidoyl-1-(4-carbamimidoyl-benzylcarbamoyl)-propylcarbamoyl]-2-methyl-butylsulfamoyl}-methyl)-benzoic acid
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
(2S)-2-[(4S,5S)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(3-hydroxy-5-oxo-1,7-diphenylheptan-4-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-5-oxo-1,7-diphenylheptyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-5-oxo-1,7-diphenylheptan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(4-hydroxy-5-oxo-1,7-diphenylheptan-3-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O8S (587.2301242000001)
[3-hydroxy-2-[(Z)-16-(81Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[(Z)-16-(79Br)bromanyl-5-hydroxyhexadec-12-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
Barasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Phosphoramidon (Disodium)
C23H32N3Na2O10P (587.1620621999999)
Phosphoramidon Disodium, a microbial metabolite, is a specific metalloprotease thermolysin inhibitor with an IC50 of 0.4 μg/mL. Phosphoramidon Disodium also inhibits endothelin-converting enzyme (ECE), neutral endopeptidase (NEP), and angiotensin-converting enzyme (ACE) with IC50 values of 3.5, 0.034, and 78 μM, respectively[1][2][3].
(3s,6s,7r)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
3α-(3,4,5-trimethoxy-cinnamoyloxy)-7β-(3,4,5-trimethoxybenzoyloxy)-6α-hydroxy-tropane
{"Ingredient_id": "HBIN007915","Ingredient_name": "3\u03b1-(3,4,5-trimethoxy-cinnamoyloxy)-7\u03b2-(3,4,5-trimethoxybenzoyloxy)-6\u03b1-hydroxy-tropane","Alias": "NA","Ingredient_formula": "C30H37NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21887","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
(1s,3s,5s,7r,10r,12s,14r,15s,18r,19r,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO8S (587.2552746000001)
14,26-dihydroxy-2-[3-hydroxy-6-(hydroxymethyl)-4-oxopyran-2-yl]-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
C32H33N3O8 (587.2267538000001)
20-[2-ethoxy-2-(2,4,5-trimethoxyphenyl)ethyl]-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene
4-{[(5s)-8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,5-dihydroxy-3-methyl-7,12-dioxo-5h-6-azatetraphen-6-yl]methyl}benzoic acid
C32H29NO10 (587.1791374000001)
(20r)-20-[(2s)-2-ethoxy-2-(2,4,5-trimethoxyphenyl)ethyl]-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene
7-hydroxy-8-methyl-3-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl 3,4,5-trimethoxybenzoate
(1r,2s,17s,19s)-14,26-dihydroxy-2-[3-hydroxy-6-(hydroxymethyl)-4-oxopyran-2-yl]-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
C32H33N3O8 (587.2267538000001)
(1s,3s,5r,6r,7r)-7-hydroxy-8-methyl-3-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl 3,4,5-trimethoxybenzoate
6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
(1s,4s,9s,10s,25s,26r)-4,22-dihydroxy-7-(hydroxymethyl)-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-6,11(23),12,14,18,20-hexaene-2,5,27-trione
C32H33N3O8 (587.2267538000001)
(1s,3r,5s,7r,9r,10r,12r,14r,15s,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO8S (587.2552746000001)
(1s,3r,5s,7r,9s,10r,12r,14r,15s,18r,19s,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO8S (587.2552746000001)
(7s,8r,9r,10r)-7-{[(2s,4s,5r,6r)-4-(dimethylamino)-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,6,9,10-tetrahydroxy-1,8-dimethoxy-9-methyl-8,10-dihydro-7h-tetracene-5,12-dione
10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO8S (587.2552746000001)
(1s,3s,5r,6r,7s)-7-hydroxy-8-methyl-3-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl 3,4,5-trimethoxybenzoate
(1s,3r,5r,6r,7s)-7-hydroxy-8-methyl-3-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl 3,4,5-trimethoxybenzoate
(1r,3s,5s,6r,7s)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate
(1s,3r,5s,7r,9s,10r,12r,14r,15r,18r,19r,22s,23r)-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-5'h-4,6,11-trioxaspiro[hexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-9,2'-[1,3]thiazole]-14-carbaldehyde
C31H41NO8S (587.2552746000001)
4,22-dihydroxy-7-(hydroxymethyl)-17,17,24,24-tetramethyl-8,16-dioxa-3,22,28-triazanonacyclo[23.6.1.0¹,²⁸.0³,²⁶.0⁴,⁹.0¹⁰,²⁶.0¹¹,²³.0¹²,²¹.0¹⁵,²⁰]dotriaconta-6,11(23),12,14,18,20-hexaene-2,5,27-trione
C32H33N3O8 (587.2267538000001)